Enveric Biosciences reported earnings of -$ 0.57 per ENVB share on Nov 13, 2026,Meanwhile, the company posted an EPS of -$ 8.18 during the same period last year, marking a
| Report Date | Nov 13, 2026 |
|---|---|
| Earnings Per Share (Surprise) | -$ 0.57 |
| Last Year's EPS | -$ 8.18 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Enveric Biosciences beat analysts’ expectations 14 times and fell short of expectations 14 time(s). Enveric Biosciences reported earnings per share of -$ 0.57 in the last report.
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | - | -$ 0.57 | -$ 10.81 | |
| Aug 14, 2026 | - | -$ 0.76 | -$ 11.64 | |
| May 15, 2026 | - | -$ 1.08 | -$ 11.64 | |
| Mar 27, 2026 | -$ 55.80 | $ 0.85 | -$ 1.22 | |
| Nov 14, 2025 | -$ 63.00 | -$ 10.81 | -$ 14.64 | |
| Aug 14, 2025 | -$ 63.00 | -$ 11.64 | -$ 57.96 | |
| Aug 11, 2025 | -$ 63.00 | -$ 11.64 | -$ 43.20 | |
| May 14, 2025 | -$ 6.00 | -$ 1.22 | -$ 45.00 | |
| May 13, 2025 | -$ 72.00 | -$ 14.64 | -$ 109.79 | |
| Mar 31, 2025 | -$ 3.45 | -$ 57.96 | -$ 9.15 | |
| Nov 14, 2024 | -$ 0.52 | -$ 43.20 | -$ 262.77 | |
| Aug 12, 2024 | -$ 0.55 | -$ 45.00 | -$ 21.89 | |
| May 15, 2024 | -$ 0.77 | -$ 109.79 | -$ 233.98 | |
| May 14, 2024 | -$ 9.15 | -$ 9.15 | -$ 547.15 | |
| Mar 26, 2024 | -$ 1.55 | -$ 262.77 | -$ 6.76 | |
| Mar 25, 2024 | -$ 23.24 | -$ 21.89 | -$ 399.56 | |
| Nov 13, 2023 | -$ 347.37 | -$ 233.98 | -$ 134.99 | |
| Aug 14, 2023 | -$ 9.75 | -$ 547.15 | -$ 21.89 | |
| Jun 8, 2023 | - | -$ 6.76 | -$ 2.47 | |
| May 15, 2023 | -$ 33.45 | -$ 399.56 | -$ 491.35 |
Enveric Biosciences’s stock was trading at $ 1.52 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.57 | $ 1.52 | ||
| Aug 14, 2026 | -$ 0.76 | $ 1.51 | $ 1.48 | |
| May 15, 2026 | -$ 1.08 | $ 2.29 | $ 2.15 | |
| Mar 27, 2026 | $ 0.85 | $ 1.86 | $ 1.79 | |
| Nov 14, 2025 | -$ 10.81 | $ 5.46 | $ 4.97 | |
| Aug 14, 2025 | -$ 11.64 | $ 13.32 | $ 13.20 | |
| Aug 11, 2025 | -$ 11.64 | $ 13.32 | $ 12.84 | |
| May 14, 2025 | -$ 1.22 | $ 17.16 | $ 15.12 | |
| May 13, 2025 | -$ 14.64 | $ 16.32 | $ 15.72 | |
| Mar 31, 2025 | -$ 57.96 | $ 17.64 | $ 15.72 | |
| Nov 14, 2024 | -$ 43.20 | $ 73.44 | $ 65.76 | |
| Aug 12, 2024 | -$ 45.00 | $ 99.00 | $ 95.76 | |
| May 15, 2024 | -$ 109.79 | $ 147.72 | $ 162.00 | |
| May 14, 2024 | -$ 9.15 | $ 151.32 | $ 141.84 | |
| Mar 26, 2024 | -$ 262.77 | $ 189.00 | $ 183.60 | |
| Mar 25, 2024 | -$ 21.89 | $ 203.40 | $ 190.80 | |
| Nov 13, 2023 | -$ 233.98 | $ 284.40 | $ 270.00 | |
| Aug 14, 2023 | -$ 547.15 | $ 489.60 | $ 428.40 | |
| Jun 8, 2023 | -$ 6.76 | $ 739.80 | $ 684.00 | |
| May 15, 2023 | -$ 399.56 | $ 261.00 | $ 258.12 |
Enveric Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
